AVR Options for the Bicuspid Patient: Case Based Discussion

AVR Options for the Bicuspid Patient: Case Based Discussion

AVR Options for the Bicuspid Patient: Case Based Discussion

Wednesday, October 14, 2020 | 7:00 PM - 8:00 PM EDT | 6:00 PM - 7:00 PM CDT

Aortic valve replacement is going through a paradigm shift. Innovation in the type of intervention and valve options has opened up new opportunities for patients and clinicians. When it comes to valve choice for long-term outcomes, durability and antithrombotic therapy becomes the crux of the discussion, as patients question the impact to their lifestyle after undergoing an aortic valve replacement. This webinar brings renowned Cardiologists and Cardiac Surgeons at the same table to have a case based discussion on AVR options.

Faculty:                

Dr. Edward Chen, Cardiovascular Surgeon, Emory University School of Medicine, Atlanta

Dr. Hector Michelena, Cardiologist, Mayo Clinic, Rochester

Dr. James Stewart, Interventional Cardiologist, Emory University School of Medicine, Atlanta

Dr. Katherine Harrington, Cardiovascular Surgeon,  Baylor Scott and White Heart Hospital Plano, Plano

Dr. Tom Nguyen,  Chief of Cardiac Surgery, McGovern Medical School Cardiothoracic and Vascular Surgery Department, Houston

 

 

The views expressed during this presentation are the speaker’s own and do not necessarily reflect those of CryoLife, the speaker’s employer, organization, committee or other group or individual.  Unattributed data, device selection, and procedural guidance is a matter of physician preference are presented on the basis of the individual speaker’s observations and experiences and should be treated accordingly. Federal law restricts the devices discussed herein to sale by or on the order of a physician. Refer to the Instructions for Use and other product insert documentation that accompanies each of these devices for indications, contraindications, warnings, precautions, possible complications, and instructions for use.  

On-X® Prosthetic Heart Valves IFU’s

Products not available in all markets.  The content of this presentation, including any copyrightable content included herein, is used with permission from the speaker.

On-X Life Technologies, Inc. is a wholly owned subsidiary of CryoLife, Inc. The On-X® Prosthetic Heart Valves are manufactured by On-X Life Technologies, Inc. The snowflake design, CryoLife, Life Restoring Technologies, and On-X are registered trademarks owned by CryoLife, Inc. or its subsidiaries. All other registered trademarks are owned by their respective owners. © 2021 CryoLife, Inc. All rights reserved.


Created by

CryoLife